OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effectiveness and safety profile of anakinra in a HLA-B27 positive patient with multiple sclerosis-associated uveitis
Giuseppe Lopalco, Sante Schiraldi, Vincenzo Venerito, et al.
Multiple Sclerosis and Related Disorders (2020) Vol. 42, pp. 102152-102152
Closed Access | Times Cited: 19
Giuseppe Lopalco, Sante Schiraldi, Vincenzo Venerito, et al.
Multiple Sclerosis and Related Disorders (2020) Vol. 42, pp. 102152-102152
Closed Access | Times Cited: 19
Showing 19 citing articles:
nELISA: A high-throughput, high-plex platform enables quantitative profiling of the secretome
Milad Dagher, Grant Ongo, Nathaniel Robichaud, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 19
Milad Dagher, Grant Ongo, Nathaniel Robichaud, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 19
A Comprehensive Update on Retinal Vasculitis: Etiologies, Manifestations and Treatments
Aniruddha Agarwal, Anne Rübsam, Lynn zur Bonsen, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 9, pp. 2525-2525
Open Access | Times Cited: 26
Aniruddha Agarwal, Anne Rübsam, Lynn zur Bonsen, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 9, pp. 2525-2525
Open Access | Times Cited: 26
Inflammatory cytokines as mediators of retinal endothelial barrier dysfunction in non‐infectious uveitis
Lísia Barros Ferreira, Keryn A. Williams, Giles Best, et al.
Clinical & Translational Immunology (2023) Vol. 12, Iss. 12
Open Access | Times Cited: 14
Lísia Barros Ferreira, Keryn A. Williams, Giles Best, et al.
Clinical & Translational Immunology (2023) Vol. 12, Iss. 12
Open Access | Times Cited: 14
Comprehensive Update on Multiple Sclerosis-Associated Uveitis and New Epidemiological Insights from the United Kingdom
Cara Heppell, Anuradhaa Subramanian, Nicola J. Adderley, et al.
Ocular Immunology and Inflammation (2025), pp. 1-13
Closed Access
Cara Heppell, Anuradhaa Subramanian, Nicola J. Adderley, et al.
Ocular Immunology and Inflammation (2025), pp. 1-13
Closed Access
Extra-Articular Manifestations and Comorbidities in Psoriatic Disease: A Journey Into the Immunologic Crosstalk
Lucia Novelli, Ennio Lubrano, Vincenzo Venerito, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 26
Lucia Novelli, Ennio Lubrano, Vincenzo Venerito, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 26
Frauke Stascheit, Anne Rübsam, Carolin Otto, et al.
European Journal of Neurology (2022) Vol. 29, Iss. 10, pp. 3028-3038
Open Access | Times Cited: 11
Rapamycin rescues loss of function in blood-brain barrier–interacting Tregs
Paulien Baeten, Ibrahim Hamad, Cindy Hoeks, et al.
JCI Insight (2024) Vol. 9, Iss. 7
Open Access | Times Cited: 2
Paulien Baeten, Ibrahim Hamad, Cindy Hoeks, et al.
JCI Insight (2024) Vol. 9, Iss. 7
Open Access | Times Cited: 2
Current Knowledge of Biologics in Treatment of Noninfectious Uveitis
Simple Gupta, Kripanidhi Shyamsundar, Mohini Agrawal, et al.
Journal of Ocular Pharmacology and Therapeutics (2022) Vol. 38, Iss. 3, pp. 203-222
Closed Access | Times Cited: 10
Simple Gupta, Kripanidhi Shyamsundar, Mohini Agrawal, et al.
Journal of Ocular Pharmacology and Therapeutics (2022) Vol. 38, Iss. 3, pp. 203-222
Closed Access | Times Cited: 10
Biologic Drugs for the Treatment of Noninfectious Uveitis
Lísia Barros Ferreira, Anthony Smith, Justine R. Smith
Asia-Pacific Journal of Ophthalmology (2021) Vol. 10, Iss. 1, pp. 63-73
Open Access | Times Cited: 14
Lísia Barros Ferreira, Anthony Smith, Justine R. Smith
Asia-Pacific Journal of Ophthalmology (2021) Vol. 10, Iss. 1, pp. 63-73
Open Access | Times Cited: 14
Management of Blau syndrome: review and proposal of a treatment algorithm
H. Ferjani, L. Kharrat, Dorra Ben Nessib, et al.
European Journal of Pediatrics (2023) Vol. 183, Iss. 1, pp. 1-7
Closed Access | Times Cited: 5
H. Ferjani, L. Kharrat, Dorra Ben Nessib, et al.
European Journal of Pediatrics (2023) Vol. 183, Iss. 1, pp. 1-7
Closed Access | Times Cited: 5
Effects of tumor necrosis factor-α and interleukin-1β on human retinal endothelial cells
Lísia Barros Ferreira, Liam M. Ashander, Yuefang Ma, et al.
Cytokine (2023) Vol. 173, pp. 156407-156407
Open Access | Times Cited: 5
Lísia Barros Ferreira, Liam M. Ashander, Yuefang Ma, et al.
Cytokine (2023) Vol. 173, pp. 156407-156407
Open Access | Times Cited: 5
Uveitis und multiple Sklerose
Nicole Stübiger, Klemens Ruprecht, Uwe Pleyer
Deleted Journal (2024) Vol. 121, Iss. 8, pp. 665-678
Closed Access | Times Cited: 1
Nicole Stübiger, Klemens Ruprecht, Uwe Pleyer
Deleted Journal (2024) Vol. 121, Iss. 8, pp. 665-678
Closed Access | Times Cited: 1
A Review of Systemic Biologics and Local Immunosuppressive Medications in Uveitis
Neesurg Mehta, Parisa Emami-Naeini
Journal of Ophthalmic and Vision Research (2022)
Open Access | Times Cited: 6
Neesurg Mehta, Parisa Emami-Naeini
Journal of Ophthalmic and Vision Research (2022)
Open Access | Times Cited: 6
Indications and Effects of Biological Agents in the Treatment of Noninfectious Uveitis
Bowen Li, Li Yang, Feng‐Ying Bai, et al.
Immunotherapy (2022) Vol. 14, Iss. 12, pp. 985-994
Closed Access | Times Cited: 5
Bowen Li, Li Yang, Feng‐Ying Bai, et al.
Immunotherapy (2022) Vol. 14, Iss. 12, pp. 985-994
Closed Access | Times Cited: 5
Progress in the pharmacotherapy of uveitis: the art of personalized care
Shivam H. Patel, Aditya Belamkar, Amir Reza Hajrasouliha, et al.
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 12, pp. 1445-1455
Closed Access | Times Cited: 4
Shivam H. Patel, Aditya Belamkar, Amir Reza Hajrasouliha, et al.
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 12, pp. 1445-1455
Closed Access | Times Cited: 4
Autologous conditioned serum for degenerative diseases and prospects
Seyed Kazem Shakouri, Sanam Dolati, Jessica Santhakumar, et al.
Growth Factors (2021) Vol. 39, Iss. 1-6, pp. 59-70
Closed Access | Times Cited: 5
Seyed Kazem Shakouri, Sanam Dolati, Jessica Santhakumar, et al.
Growth Factors (2021) Vol. 39, Iss. 1-6, pp. 59-70
Closed Access | Times Cited: 5
Rituximab in the Treatment of Non-Infectious Uveitis: A Review
Haixing Cao, Xiang Ma
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 6765-6780
Open Access
Haixing Cao, Xiang Ma
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 6765-6780
Open Access
Inflammasomes in Diseases of the Posterior Segment
S M Coyle, Victoria McGilligan, Colin E. Willoughby, et al.
Elsevier eBooks (2024)
Closed Access
S M Coyle, Victoria McGilligan, Colin E. Willoughby, et al.
Elsevier eBooks (2024)
Closed Access
Rapamycin rescues loss-of-function in blood-brain barrier-interacting regulatory T cells
Paulien Baeten, Ibrahim Hamad, Cindy Hoeks, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Paulien Baeten, Ibrahim Hamad, Cindy Hoeks, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
